This page lists all the PDB deposits that contain a P450 protein chain.
This list has been updated on January 1st, 2026. The entries have been named by the P450Atlas and subsequently manually verified.
The chain_id column provide the representative chain for each deposit.
| PDB_id | chain_id | cyp_id | deposition date | method | resolution | title | 9YVV | A | CYP1468A1 | 2025-10-23 | X-ray | 2.32 | Cocrystallized structure of Bmp7 in complex with 2,4-dibromophenol | 9YV5 | A | CYP1468A1 | 2025-10-23 | X-ray | 2.28 | Crystal structure of cytochrome P450 enzyme Bmp7 | 9YK4 | A | CYP3A4 | 2025-10-06 | X-ray | 1.78 | Crystal structure of CYP3A4 bound to imidazole and tetraethylene glycol | 9SI5 | D | CYP129A2 | 2025-08-28 | X-ray | 2.54 | Crystal structure of DoxA in complex with reaction intermediate DHD | 9WAT | A | CYP204A3 | 2025-08-12 | X-ray | 2.1 | Crystal structure of CYP204A3 | 9S7F | D | CYP129A2 | 2025-08-04 | X-ray | 1.767 | Crystal structure of DoxA in complex with substrate DOD | 9PLK | A | CYP3A4 | 2025-07-15 | X-ray | 2.25 | Interaction of human CYP3A4 with the drug darifenacin | 9PLJ | A | CYP3A4 | 2025-07-15 | X-ray | 2.72 | Crystal structure of human CYP3A4 with substrate THC | 9RXH | B | CYP152L7 | 2025-07-11 | X-ray | 1.83 | Cytochrome P450 decarboxylase from Staphylococcus aureus (OleT_Sa) with elaidic acid and acetate bound | 9VL0 | A | CYP105A1 | 2025-06-24 | X-ray | 1.6 | CYP105A1 complexed with simvastatin (cryogenic data collection) | 9ONH | A | CYP11A1 | 2025-05-15 | X-ray | 2.9 | Structure of ancestral-reconstructed cytochrome P450 11A1 (CYP11A1) in complex with desmosterol | 9O35 | B | CYP129A2 | 2025-04-04 | X-ray | 2.19 | Crystal structure of DoxA in complex with daunorubicin | 9U53 | A | CYP154C2 | 2025-03-20 | X-ray | 1.97 | Crystal structure of the CYP154C2 Q230A from Streptomyces avermitilis | 9NNE | A | CYP46A1 | 2025-03-05 | X-ray | 1.95 | Crystal structure of CYP46A1 with (morpholin-4-yl)[(4R,8M)-8-(1,3-oxazol-5-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]methanone (compound 2h) | 9NNI | A | CYP46A1 | 2025-03-05 | X-ray | 1.7 | Crystal structure of CYP46A1 with cyclopropyl[(4M)-4-(1,3-oxazol-5-yl)-6-(trifluoromethyl)-1H-indol-1-yl]methanone (compound 2b) | 9NNO | A | CYP46A1 | 2025-03-05 | X-ray | 1.8 | Crystal structure of CYP46A1 with N-[6-(1,3-oxazol-5-yl)-4-(trifluoromethyl)pyridin-2-yl]cyclopropanecarboxamide (compound 4l) | 9NNM | A | CYP46A1 | 2025-03-05 | X-ray | 1.7 | Crystal structure of CYP46A1 with 3-chloro-N-[(3M)-3-(1,3-oxazol-5-yl)-5-(trifluoromethyl)phenyl]benzamide (compound 3f) | 9NNJ | A | CYP46A1 | 2025-03-05 | X-ray | 2.29 | Crystal structure of CYP46A1 with 3-chloro-N-[(3M)-3-(1,3-oxazol-5-yl)phenyl]-N-(propan-2-yl)benzene-1-sulfonamide (compound 2) | 9NNA | A | CYP46A1 | 2025-03-05 | X-ray | 1.67 | Crystal structure of CYP46A1 with [(1R,5S)-3-oxa-8-azabicyclo[3.2.1]octan-8-yl][(4R,8M)-8-(1,3-oxazol-5-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]methanone (compound 3k) | 9NJW | A | CYP11A1 | 2025-02-28 | X-ray | 2.4 | Structure of ancestral-reconstructed cytochrome P450 11A1 (CYP11A1) in complex with cholesterol | 9LN5 | A | CYP107E6 | 2025-01-20 | X-ray | 2.13 | Crystal structure of P450revI A241L mutant in complex with reveromycin T | 9MS3 | A | CYP1468A1 | 2025-01-09 | X-ray | 2.25 | Crystal structure of Bmp7 in complex with 2,4-dibromophenol generated by substrate soaking | 9MS2 | B | CYP3A5 | 2025-01-09 | X-ray | 2.25 | Crystal structure of human CYP3A5 in complex with SJYHJ-111 | 9MS1 | A | CYP3A4 | 2025-01-09 | X-ray | 3.4 | Crystal structure of human CYP3A4 in complex with SJYHJ-111 | 9L7V | B | CYP102A1 | 2024-12-27 | X-ray | 2.02 | Crystal structure of P450 BM3 F87A/V78G mutant complex with (-)-Ambroxide | 9L7S | H | CYP102A1 | 2024-12-27 | X-ray | 2.1 | Crystal structure of P450 BM3 F87A/V78S mutant | 9L7T | B | CYP102A1 | 2024-12-27 | X-ray | 1.98 | Crystal structure of P450 BM3 F87A/V78S mutant complex with (-)-Ambroxide | 9L7U | B | CYP102A1 | 2024-12-27 | X-ray | 2.7 | Crystal structure of P450 BM3 F87A/V78S/L75N mutant complex with (-)-Ambroxide | 9L7Q | B | CYP101A1 | 2024-12-27 | X-ray | 1.82 | Crystal structure of P450cam-F87R mutant | 9L7R | B | CYP101A1 | 2024-12-27 | X-ray | 2.04 | Crystal structure of P450cam-F87R mutant complex with (-)-ambroxide | 9KW5 | A | CYP105A1 | 2024-12-05 | X-ray | 2.1 | Crystal structure of CYP105A1 R84A, diclofenac and lanoconazole complex | 9KW4 | A | CYP105A1 | 2024-12-05 | X-ray | 1.8 | Crystal structure of CYP105A1 R84A and miconazole complex | 9KW2 | A | CYP105A1 | 2024-12-05 | X-ray | 1.8 | Crystal structure of CYP105A1 R84A and ketoconazole complex | 9KW3 | A | CYP105A1 | 2024-12-05 | X-ray | 1.8 | Crystal structure of CYP105A1 R84A and lanoconazole complex | 9KT5 | B | CYP102A1 | 2024-12-01 | X-ray | 1.6 | Synchrotron X-ray crystal structure of oxygen-bound F87A/F393H P450BM3 with decoy C7ProPhe (N-enanthyl-L-prolyl-L-phenylalanine) and substrate styrene at 2 MGy X-ray dose | 9KPU | B | CYP107PW1 | 2024-11-24 | X-ray | 2.3 | Crystal structure of FrazP2 in complex with forazoline C | 9KPP | A | CYP107PW1 | 2024-11-23 | X-ray | 1.85 | Crystal structure of FrazP2 | 9KKI | B | CYP153A33 | 2024-11-13 | X-ray | 2.2 | Crystal structure of the CYP153A double mutant L354V/V456G from Marinobacter aquaeolei | 9EBY | A | CYP1251G1 | 2024-11-13 | X-ray | 2.03 | Crystal structure of RufO in complex with MRYLH | 9KGP | B | CYP102A1 | 2024-11-08 | X-ray | 1.52 | The structure of natural P450BM3-H derived from Bacillus megaterium for catalyzing the steroid DHEA | 9KG5 | B | CYP154C5 | 2024-11-07 | X-ray | 1.85 | Crystal structure of the CYP154C5 F92A/R114A/T248D/E282A variant from Nocardia farcinica | 9DZR | B | CYP199A28 | 2024-10-16 | X-ray | 1.733 | The crystal structure of F182AQE CYP199A4 bound to 4-methylthiobenzoic acid | 9DYC | A | CYP199A28 | 2024-10-13 | X-ray | 2.2 | The crystal structure of F182A CYP199A4 bound to 4-ethylbenzoic acid | 9DY5 | A | CYP199A28 | 2024-10-13 | X-ray | 2.5 | The crystal structure of F182A CYP199A4 bound to 4-methylthiobenzoic acid | 9DY9 | A | CYP199A28 | 2024-10-13 | X-ray | 1.672 | The crystal structure of F182A CYP199A4 bound to 4-methoxybenzoic acid | 9DXW | A | CYP199A28 | 2024-10-11 | X-ray | 2.05 | The crystal structure of F182A CYP199A4 bound to 4-t-butylbenzoic acid | 9DX9 | A | CYP199A28 | 2024-10-10 | X-ray | 1.52 | The crystal structure of F182AQE CYP199A4 bound to 4-t-butylbenzoic acid | 9DX8 | A | CYP199A28 | 2024-10-10 | X-ray | 1.679 | The crystal structure of F182AQE CYP199A4 bound to 4-vinylbenzoic acid | 9DWR | A | CYP199A28 | 2024-10-10 | X-ray | 1.8 | The crystal structure of F182AQE CYP199A4 bound to 4-methoxybenzoic acid | 9DUJ | A | CYP1251G1 | 2024-10-03 | X-ray | 1.51 | Crystal structure of RufO in complex with (Nle)RYLH | 9JS9 | B | CYP154C5 | 2024-09-30 | X-ray | 1.89 | Crystal structure of the CYP154C5 F92A/R114A/T248G/E282A variant from Nocardia farcinica | 9JQM | B | CYP152L14 | 2024-09-27 | X-ray | 2.44 | X-ray structure of cytochrome P450 OleT from Lacicoccus alkaliphilus in complex with icosanoic acid | 9DOE | A | CYP199A28 | 2024-09-19 | X-ray | 1.265 | The high-resolution crystal structure of WT CYP199A4 bound to 4-methoxybenzoic acid at 100 K | 9JL5 | A | CYP105A1 | 2024-09-18 | X-ray | 1.8 | CYP105A1 R84A complexed with mevastatin (cryogenic data collection) | 9JKZ | A | CYP105A1 | 2024-09-17 | X-ray | 2.4 | CYP105A1 R84A complexed with simvastatin | 9JKW | A | CYP105A1 | 2024-09-17 | X-ray | 2.19 | CYP105A1 R84A complexed with mevastatin | 9JIP | A | CYP105A1 | 2024-09-12 | X-ray | 1.68 | CYP105A1 R84A complexed with flufenamic acid (FLF) | 9JI1 | A | CYP105A1 | 2024-09-11 | X-ray | 1.47 | CYP105A1 complexed with flufenamic acid (FLF) | 9JI6 | A | CYP105A1 | 2024-09-11 | X-ray | 1.55 | CYP105A1 R84A complexed with diclofenac (DIF) | 9JHW | A | CYP105A1 | 2024-09-10 | X-ray | 1.4 | CYP105A1 complexed with diclofenac (DIF) | 9GK1 | A | CYP3A4 | 2024-08-23 | X-ray | 2.95 | SSX structure of human cytochrome P450 3A4 at room temperature | 9IXL | B | CYP153A33 | 2024-07-29 | X-ray | 2.1 | Crystal structure of the CYP153A double mutant L354T/V456G from Marinobacter aquaeolei | 9IY1 | F | CYP152A1 | 2024-07-29 | X-ray | 2.29 | P450 BS beta mutant F46A | 9cv8 | A | CYP161A1 | 2024-07-28 | X-ray | 2.0 | Crystal Structure of Cytochrome P450 NysL bound to nystatin | 9g9q | B | CYP199A3 | 2024-07-25 | X-ray | 2.03 | Crystal structure of PbdA bound to p-methoxybenzoate. | 9g9s | A | CYP199A3 | 2024-07-25 | X-ray | 1.85 | Crystal structure of PbdA bound to veratrate | 9g9r | A | CYP199A3 | 2024-07-25 | X-ray | 1.65 | Crystal structure of PbdA bound to p-ethylbenzoate | 9iss | A | CYP102A1 | 2024-07-18 | X-ray | 1.46 | Crystal Structure of Cytochrome P450BM3 III-10C1 Mutant Heme Domain with N-Decanoyl-L-Homoserine Lactone | 9ist | A | CYP102A1 | 2024-07-18 | X-ray | 2.27 | Crystal Structure of Cytochrome P450BM3 VI-18A12 Mutant Heme Domain with N-Decanoyl-L-Homoserine Lactone | 9isu | A | CYP102A1 | 2024-07-18 | X-ray | 1.32 | Crystal Structure of Cytochrome P450BM3 V-19A14 Mutant Heme Domain with N-Decanoyl-L-Homoserine Lactone | 9cor | A | CYP3A4 | 2024-07-17 | X-ray | 2.55 | Crystal structure of CYP3A4 bound to an inhibitor | 9cos | A | CYP3A4 | 2024-07-17 | X-ray | 2.75 | Crystal structure of CYP3A4 bound to an inhibitor | 9cot | A | CYP3A4 | 2024-07-17 | X-ray | 2.81 | Crystal structure of CYP3A4 bound to an inhibitor | 9cow | A | CYP3A4 | 2024-07-17 | X-ray | 2.3 | Crystal structure of CYP3A4 bound to an inhibitor | 9cox | A | CYP3A4 | 2024-07-17 | X-ray | 2.72 | Crystal structure of CYP3A4 bound to an inhibitor | 9cou | A | CYP3A4 | 2024-07-17 | X-ray | 2.81 | Crystal structure of CYP3A4 bound to an inhibitor | 9cov | A | CYP3A4 | 2024-07-17 | X-ray | 2.6 | Crystal structure of CYP3A4 bound to an inhibitor | 9coy | A | CYP3A4 | 2024-07-17 | X-ray | 2.65 | Crystal structure of CYP3A4 bound to an inhibitor | 9bw8 | B | CYP1251C3 | 2024-05-21 | X-ray | 1.86 | Structure of P450Blt from Micromonospora sp. MW-13 in Complex with Fluorinated Biarylitide | 8yz8 | B | CYP121A7 | 2024-04-06 | X-ray | 2.86 | Crystal structure of PtmB in complex with Adenine | 8yza | A | CYP121A7 | 2024-04-06 | X-ray | 2.0 | Crystal structure of PtmB in complex with cyclo-(L-Trp-L-Trp) and Guanine | 9bbb | A | CYP3A4 | 2024-04-05 | X-ray | 2.5 | Human CYP3A4 bound to an inhibitor | 8yyp | B | CYP121A7 | 2024-04-04 | X-ray | 2.6 | Crystal structure of PtmB in complex with cyclo-(L-Trp-L-Trp) and Adenine | 8yy7 | A | CYP121A7 | 2024-04-03 | X-ray | 2.1 | Crystal structure of PtmB in complex with cyclo-(L-Trp-L-Trp) and Hypoxanthine | 8yxt | A | CYP121A7 | 2024-04-02 | X-ray | 2.6 | Crystal structure of PtmB | 8s53 | A | CYP142A1 | 2024-02-22 | X-ray | 1.6 | X-ray crystal structure of CYP142 from Mycobacterium tuberculosis in complex with a fragment bound in two poses | 8s4m | B | CYP125A1 | 2024-02-21 | X-ray | 2.1 | Crystal structure of Mycobacterium tuberculosis cytochrome P450 CYP125 in complex with an inhibitor | 8w1k | B | CYP152AX1 | 2024-02-16 | X-ray | 1.7 | Crystal Structure of a fatty acid decarboxylase from Corynebacterium lipophiloflavum in complex with oleic acid | 8w1j | C | CYP152AX1 | 2024-02-16 | X-ray | 1.8 | Crystal Structure of a fatty acid decarboxylase from Corynebacterium lipophiloflavum in complex with palmitic acid | 8yay | A | CYP102A1 | 2024-02-11 | X-ray | 1.8 | XFEL crystal structure of the oxidized form of F393H P450BM3 with N-enanthyl-L-prolyl-L-phenylalanine in complex with styrene | 8yb2 | A | CYP102A1 | 2024-02-11 | X-ray | 1.5 | XFEL crystal structure of the oxygen-bound form of F393H P450BM3 with N-enanthyl-L-prolyl-L-phenylalanine in complex with styrene | 8yb0 | A | CYP102A1 | 2024-02-11 | X-ray | 1.6 | XFEL crystal structure of the reduced form of F393H P450BM3 with N-enanthyl-L-prolyl-L-phenylalanine in complex with styrene | 8yaz | A | CYP102A1 | 2024-02-11 | X-ray | 1.85 | XFEL crystal structure of the oxidized form of F87A/F393H P450BM3 with N-enanthyl-L-prolyl-L-phenylalanine in complex with styrene | 8yb1 | A | CYP102A1 | 2024-02-11 | X-ray | 1.6 | XFEL crystal structure of the reduced form of F87A/F393H P450BM3 with N-enanthyl-L-prolyl-L-phenylalanine in complex with styrene | 8yb3 | A | CYP102A1 | 2024-02-11 | X-ray | 1.5 | XFEL crystal structure of the oxygen-bound form of F87A/F393H P450BM3 with N-enanthyl-L-prolyl-L-phenylalanine in complex with styrene | 8vz7 | A | CYP2C9 | 2024-02-11 | X-ray | 2.53 | Crystal Structure of Human Cytochrome P450 2C9*27 (R150L) Genetic Variant in Complex with the Drug Losartan | 8vx0 | A | CYP2C9 | 2024-02-02 | X-ray | 3.05 | CRYSTAL STRUCTURE OF CYP2C9*14 IN COMPLEX WITH LOSARTAN | 8vwk | A | CYP152T10 | 2024-02-01 | X-ray | 2.05 | Crystal Structure of a fatty acid decarboxylase from Kocuria marina in complex with myristic acid | 8rtv | A | CYP154E1 | 2024-01-29 | X-ray | 2.002 | Crystal structure of CYP154E1 from Thermobifida fusca YX in complex with 4-Phenylimidazole | 8vl0 | A | CYP199A4 | 2024-01-11 | X-ray | 1.837 | The crystal structure of wild-type CYP199A4 bound to 4-(2-oxopropyl)benzoic acid | 8vkf | A | CYP199A4 | 2024-01-09 | X-ray | 1.7 | The crystal structure of wild-type CYP199A4 bound to 4-propionylbenzoic acid | 8vk6 | A | CYP51F1 | 2024-01-08 | X-ray | 1.89 | 14alpha-demethylase (CYP51) with amide-linked long arm extension antifungal azole inhibitor | 8vf0 | A | CYP199A4 | 2023-12-21 | X-ray | 2.028 | The crystal structure of QE CYP199A4 bound to 4-methoxybenzoic acid | 8vfr | A | CYP199A4 | 2023-12-21 | X-ray | 2.018 | The crystal structure of 4-methylbenzoic acid-bound GALQE CYP199A4 after soaking in 10 mM H2O2 for 5 minutes | 8vfp | A | CYP199A4 | 2023-12-21 | X-ray | 2.7 | The crystal structure of GALQE CYP199A4 bound to 4-methylbenzoic acid | 8vf3 | A | CYP199A4 | 2023-12-21 | X-ray | 1.469 | The crystal structure of GALQE CYP199A4 bound to 4-methoxybenzoic acid | 8x3e | A | CYP725A4 | 2023-11-13 | X-ray | 2.5 | CYP725A4-Taxa-4,11-diene complex | 8x1w | A | CYP725A4 | 2023-11-09 | X-ray | 2.1 | CYP725A4 apo structure | 8qzf | A | CYP102A1 | 2023-10-27 | X-ray | 1.8 | Heme-domain BM3 mutant T268E | 8qze | A | CYP102A1 | 2023-10-27 | X-ray | 1.87 | Heme-domain BM3 variant 21B3_F87V-A328F | 8qyi | C | CYP107D1 | 2023-10-26 | X-ray | 2.3 | OleP in complex with lithocholic acid in high salt crystallization conditions | 8ws4 | A | CYP199A4 | 2023-10-16 | X-ray | 1.53 | Crystal structure of the CYP199A4 mutant F182A in complex with 4-methoxybenzoic acid | 8ukz | B | CYP1251C3 | 2023-10-15 | X-ray | 1.95 | Structure of P450Blt from Micromonospora sp. MW-13 with E238A Mutation | 8qrd | A | CYP107D1 | 2023-10-06 | X-ray | 2.3 | OleP in complex with testosterone in high salt crystallization conditions | 8u3n | B | CYP1251C3 | 2023-09-08 | X-ray | 2.15 | Structure of P450Blt from Micromonospora sp. MW-13 | 8u2m | B | CYP1251C3 | 2023-09-06 | X-ray | 1.79 | Structure of P450Blt from Micromonospora sp. MW-13 in Complex with Biarylitide | 8u1i | A | CYP255D1 | 2023-09-01 | X-ray | 1.12 | Crystal structure of SyoA bound to 4-methylsyringol | 8u19 | A | CYP255D1 | 2023-08-31 | X-ray | 1.26 | Crystal structure of SyoA bound to syringol | 8w7g | A | CYP161H12 | 2023-08-30 | X-ray | 1.8 | Crystal structure of cytochrome P450 CYP161H12 from Amycolatopsis pretoriensis | 8w72 | A | CYP107CE1 | 2023-08-30 | X-ray | 3.25 | Crystal structure of a P450 enzyme DmlH that catalyze intramolecular phenol coupling in the biosynthesis of cihanmycins | 8w6z | A | CYP107CE1 | 2023-08-30 | X-ray | 2.2 | Substrate-bound crystal structure of a P450 enzyme DmlH that catalyze intramolecular phenol coupling in the biosynthesis of cihanmycins | 8u09 | A | CYP255D1 | 2023-08-28 | X-ray | 1.98 | Crystal structure of substrate-free SyoA | 8twu | A | CYP1190B1 | 2023-08-21 | X-ray | 1.84 | Crystal structure of Cytochrome P450 AspB bound to N1-methylated cyclo-L-Trp-L-Pro | 8q6z | A | CYP121A8 | 2023-08-15 | X-ray | 1.96 | Crystal structure of Cytochrome P450 GymB1 from Streptomyces flavidovirens | 8q6x | A | CYP121A7 | 2023-08-15 | X-ray | 1.91 | Crystal structure of Cytochrome P450 GymB5 from Streptomyces katrae | 8q6y | A | CYP121A7 | 2023-08-15 | X-ray | 1.81 | Crystal structure of Cytochrome P450 GymB5 from Streptomyces katrae in complex with cYY and Hypoxanthine | 8q5j | A | CYP1085B1 | 2023-08-09 | X-ray | 1.48 | Cytochrome P450 monooxygenase from Streptomyces scabiei (SscaCYP) | 8tnk | A | CYP199A4 | 2023-08-02 | X-ray | 1.79 | The crystal structure of the T252E mutant of CYP199A4 bound to 4-benzylbenzoic acid | 8q2f | E | CYP102A1 | 2023-08-02 | X-ray | 3.43 | Cytochrome P450 BM3 aMOx-A heme domain | 8k1x | A | CYP244A14 | 2023-07-11 | X-ray | 2.27 | Biochemical and structural characterization of a multifunctional cytochrome P450 SpcN in staurosporine biosynthesis | 8tdq | A | CYP121A1 | 2023-07-04 | X-ray | 1.65 | SFX-XFEL structure of CYP121 cocrystallized with substrate cYY | 8tdp | A | CYP121A1 | 2023-07-04 | X-ray | 1.85 | Time-resolved SFX-XFEL crystal structure of CYP121 bound with cYY reacted with peracetic acid for 200 milliseconds | 8tay | A | CYP199A4 | 2023-06-28 | X-ray | 2.021 | The crystal structure of T252E CYP199A4 bound to 4-(thiophen-3-yl)benzoic acid | 8taw | A | CYP199A4 | 2023-06-28 | X-ray | 1.73 | The crystal structure of T252E CYP199A4 bound to 4-(pyridin-2-yl)benzoic acid | 8jua | A | CYP107LF1 | 2023-06-26 | X-ray | 2.0000111155 | Multifunctional cytochrome P450 enzyme IkaD from Streptomyces sp. ZJ306, in complex with epoxyikarugamycin | 8jrl | A | CYP107E48 | 2023-06-17 | X-ray | 2.07 | Crystal structure of P450 TleB with an indole alkaloid | 8joo | A | CYP107LF1 | 2023-06-08 | X-ray | 2.25 | Crystal structure of cytochrome P450 IkaD from Streptomyces sp. ZJ306, in complex with the substrate ikarugamycin | 8jnc | A | CYP107LF1 | 2023-06-06 | X-ray | 2.0 | Crystal structure of cytochrome P450 IkaD from Streptomyces sp. ZJ306, in complex with the substrate 10-epi-maltophilin | 8jno | A | CYP107LF1 | 2023-06-06 | X-ray | 2.0 | Crystal structure of cytochrome P450 IkaD from Streptomyces sp. ZJ306, in complex with the substrate 10-epi-deOH-HSAF | 8jnq | A | CYP107LF5 | 2023-06-06 | X-ray | 2.0 | Crystal structure of cytochrome P450 CftA from Streptomyces torulosus NRRL B-3889, in complex with a substrate compound c | 8jnp | A | CYP107LF5 | 2023-06-06 | X-ray | 2.0 | Crystal structure of cytochrome P450 CftA from Streptomyces torulosus NRRL B-3889, in complex with the substrate ikarugamycin | 8swl | A | CYP105Q4 | 2023-05-19 | X-ray | 3.06 | Substrate free structure of cytochrome P450 CYP105Q4 from mycobacterium marinum | 8jc3 | B | CYP102A1 | 2023-05-10 | X-ray | 1.82 | Crystal structure of the P450 BM3 heme domain mutant F87A-T268V in complex with Pyd-N-C4-Phe and hydroxylamine | 8jc4 | B | CYP102A1 | 2023-05-10 | X-ray | 2.64 | Crystal structure of the P450 BM3 heme domain mutant F87A-T268V in complex with Pyd-Pid-Phe and hydroxylamine | 8ss0 | A | CYP51A1 | 2023-05-08 | X-ray | 2.25 | Human sterol 14 alpha-demethylase (CYP51) in complex with the reaction intermediate 14 alpha-aldehyde dihydrolanosterol | 8spp | A | CYP1251A1 | 2023-05-03 | X-ray | 1.89 | Crystal structure of a heme enzyme RufO in rufomycin biosynthesis | 8spd | A | CYP3A4 | 2023-05-02 | X-ray | 2.9 | Cytochrome P450 (CYP) 3A4 crystallized with clotrimazole | 8spc | A | CYP1251A1 | 2023-05-02 | X-ray | 1.871 | Crystal structure of the cytochrome P450 enzyme RufO | 8so2 | A | CYP3A4 | 2023-04-28 | X-ray | 2.15 | Human CYP3A4 bound to a substrate | 8so1 | A | CYP3A4 | 2023-04-28 | X-ray | 2.05 | Human CYP3A4 bound to three caffeine molecules | 8sg5 | A | CYP3A5 | 2023-04-11 | X-ray | 2.8 | Cytochrome P450 (CYP) 3A5 crystallized with clotrimazole | 8sbi | A | CYP51A1 | 2023-04-03 | X-ray | 2.73 | Crystal structure of human sterol 14 alpha-demethylase (CYP51) in the ligand-free state | 8gm2 | A | CYP199A4 | 2023-03-24 | X-ray | 2.33 | Crystal structure of T252E-CYP199A4 in complex with 4-methoxybenzoic acid soaked with 2 mM hydrogen peroxide | 8gm1 | A | CYP199A4 | 2023-03-24 | X-ray | 1.85 | Crystal structure of T252E-CYP199A4 in complex with 4-methoxybenzoic acid soaked with 1 mM hydrogen peroxide | 8glz | A | CYP199A4 | 2023-03-23 | X-ray | 2.02 | Crystal structure of T252E-CYP199A4 in complex with 4-hydroxybenzoic acid. Crystal was initially co-crystallised with 4-methoxybenzoic acid and soaked with 4 mM hydrogen peroxide | 8gly | A | CYP199A4 | 2023-03-23 | X-ray | 2.03 | Crystal structure of T252E-CYP199A4 in complex with 4-hydroxybenzoic acid | 8gk3 | A | CYP3A7 | 2023-03-16 | X-ray | 2.6 | Cytochrome P450 3A7 in complex with Dehydroepiandrosterone sulfate | 8gdi | A | CYP124A1 | 2023-03-06 | X-ray | 1.81 | X-ray crystal structure of CYP124A1 from Mycobacterium Marinum in complex with 7-ketocholesterol | 8ckn | A | CYP143A1 | 2023-02-16 | X-ray | 1.54 | Cytochrome P450 CYP143A1 (Rv1785c) from Mycobacterium tuberculosis | 8g36 | A | CYP199A4 | 2023-02-06 | X-ray | 2.1 | Crystal structure of F182L-CYP199A4 in complex with terephthalic acid | 8g35 | A | CYP199A4 | 2023-02-06 | X-ray | 2.0 | Crystal structure of F182L-CYP199A4 in complex with (S)-4-(2-hydroxy-3-oxobutan-2-yl)benzoic acid | 8fz8 | A | CYP107CF2 | 2023-01-27 | X-ray | 1.43 | Structure of cytochrome P450sky2 | 8c9i | A | CYP141A1 | 2023-01-23 | X-ray | 2.05 | Cytochrome P450 CYP141A1 (Rv3121) from Mycobacterium tuberculosis | 8flo | A | CYP124A1 | 2022-12-22 | X-ray | 1.71 | X-ray crystal structure of substrate free CYP124A1 from Mycobacterium Marinum | 8fkb | A | CYP124A1 | 2022-12-21 | X-ray | 1.42 | X-ray crystal structure of CYP124A1 from Mycobacterium Marinum bound to Farnesol | 8fjo | A | CYP124A1 | 2022-12-20 | X-ray | 1.69 | X-ray crystal structure of CYP124A1 from Mycobacterium Marinum in complex with farnesyl acetate | 8fid | A | CYP114A15 | 2022-12-16 | X-ray | 1.83 | Crystal Structure of Erwinia tracheiphila CYP114 in complex with ent-kaurenoic acid (Crystal Form 2) | 8fic | A | CYP114A15 | 2022-12-16 | X-ray | 1.7 | Crystal Structure of Erwinia tracheiphila CYP114 in complex with ent-kaurenoic acid (Crystal Form 1) | 8fib | A | CYP114A15 | 2022-12-16 | X-ray | 1.68 | Crystal Structure of Erwinia tracheiphila CYP114 | 8fie | A | CYP114A15 | 2022-12-16 | X-ray | 2.26 | Crystal Structure of Erwinia tracheiphila CYP114 mutant - A261D | 8hot | B | CYP102A1 | 2022-12-10 | X-ray | 1.96 | Crystal structure of the P450 BM3 heme domain mutant F87A in complex with NH2-C7-Phe-Phe | 8hos | B | CYP102A1 | 2022-12-10 | X-ray | 1.82 | Crystal structure of the P450 BM3 heme domain mutant F87A in complex with Im-C6-Phe(4NO2)-Tyr | 8hor | B | CYP102A1 | 2022-12-10 | X-ray | 1.95 | Crystal structure of the P450 BM3 heme domain mutant F87A in complex with Im-C6-Phe(4CH3)-Tyr | 8hoq | B | CYP102A1 | 2022-12-10 | X-ray | 1.94 | Crystal structure of the P450 BM3 heme domain mutant F87A in complex with Im-C6-Phe(4CF3)-Tyr | 8hop | B | CYP102A1 | 2022-12-10 | X-ray | 1.86 | Crystal structure of the P450 BM3 heme domain mutant F87A in complex with Im-C6-Nap-Tyr | 8hoo | A | CYP102A1 | 2022-12-10 | X-ray | 1.86 | Crystal structure of the P450 BM3 heme domain mutant F87A in complex with Im-C6-Tyr-Nap | 8hon | A | CYP102A1 | 2022-12-10 | X-ray | 2.01 | Crystal structure of the P450 BM3 heme domain mutant F87A in complex with Im-C6-Tyr-Tyr | 8hou | A | CYP102A1 | 2022-12-10 | X-ray | 1.75 | Crystal structure of the P450 BM3 heme domain mutant F87A-T268V in complex with Im-N-C4-Phe-Phe | 8ho1 | A | CYP1190B1 | 2022-12-09 | X-ray | 2.0 | Crystal structure of cytochrome P450 NasF5053 mutant F387G | 8ho0 | A | CYP1190B1 | 2022-12-09 | X-ray | 1.71 | Crystal structure of cytochrome P450 NasF5053 mutant E73S complexed with 8FCWP | 8hny | A | CYP1190B1 | 2022-12-09 | X-ray | 2.1 | Crystal structure of cytochrome P450 NasF5053 mutant E73S complexed with 5FCWP | 8hnz | A | CYP1190B1 | 2022-12-09 | X-ray | 1.5 | Crystal structure of cytochrome P450 NasF5053 mutant E73S complexed with 6FCWP | 8fda | A | CYP17A1 | 2022-12-02 | X-ray | 2.2 | Human Cytochrome P450 17A1 in complex with steroidal isonitrile inhibitor | 8fbc | A | CYP203A20 | 2022-11-29 | X-ray | 1.53 | Crystal structure of P450T2 | 8hkj | B | CYP102A5 | 2022-11-27 | X-ray | 2.8 | Crystal structure of the CYP102A5 haem Domain isolated from Bacillus cereus | 8hkd | B | CYP152A1 | 2022-11-25 | X-ray | 2.35 | Crystal structure of P450BSbeta-L78G/Q85F/F173S/G290I variant in complex with palmitoleic acid | 8f91 | A | CYP165B12 | 2022-11-22 | X-ray | 2.8 | OxyB, a cytochrome P450 involved in keratinimicin biosynthesis | 8hgt | A | CYP153A33 | 2022-11-15 | X-ray | 2.06 | Crystal structure of the CYP153A mutant V456A from Marinobacter aquaeolei | 8hg9 | A | CYP106A6 | 2022-11-14 | X-ray | 2.79 | Cytochrome P450 steroid hydroxylase (BaCYP106A6) from Bacillus species | 8hgc | A | CYP199A4 | 2022-11-14 | X-ray | 1.72 | Crystal structure of the CYP199A4 mutant F182T in complex with 4-methoxybenzoic acid | 8hgb | A | CYP199A4 | 2022-11-14 | X-ray | 1.54 | Crystal structure of the CYP199A4 mutant F182G in complex with 3-hydroxy-4-methoxybenzoic acid | 8hge | B | CYP153A33 | 2022-11-14 | X-ray | 1.53 | Crystal structure of the CYP153A mutant V456A from Marinobacter aquaeolei in complex with 12-hydroxydodecanoic acid | 8hgd | B | CYP153A33 | 2022-11-14 | X-ray | 1.53 | Crystal structure of the CYP153A mutant V456A from Marinobacter aquaeolei | 8exb | A | CYP3A4 | 2022-10-25 | X-ray | 2.05 | Crystal structure of CYP3A4 bound to an inhibitor | 8ewq | A | CYP3A4 | 2022-10-24 | X-ray | 2.25 | Crystal structure of CYP3A4 bound to an inhibitor | 8ewp | A | CYP3A4 | 2022-10-24 | X-ray | 2.4 | Crystal structure of CYP3A4 bound to an inhibitor | 8ews | A | CYP3A4 | 2022-10-24 | X-ray | 2.15 | Crystal structure of CYP3A4 bound to an inhibitor | 8ewr | A | CYP3A4 | 2022-10-24 | X-ray | 2.2 | Crystal structure of CYP3A4 bound to an inhibitor | 8ewn | A | CYP3A4 | 2022-10-24 | X-ray | 2.1 | Crystal structure of CYP3A4 bound to an inhibitor | 8ewl | A | CYP3A4 | 2022-10-24 | X-ray | 2.35 | Crystal structure of CYP3A4 bound to an inhibitor | 8ewm | A | CYP3A4 | 2022-10-24 | X-ray | 2.3 | Crystal structure of CYP3A4 bound to an inhibitor | 8ewe | A | CYP3A4 | 2022-10-22 | X-ray | 2.3 | Crystal structure of CYP3A4 bound to an inhibitor | 8ewd | A | CYP3A4 | 2022-10-22 | X-ray | 2.2 | Crystal structure of CYP3A4 bound to an inhibitor | 8euk | A | CYP108A1 | 2022-10-18 | X-ray | 1.98 | cytochrome P450terp (cyp108A1) bound to ethylene glycol | 8euh | A | CYP108A1 | 2022-10-18 | X-ray | 2.0 | cytochrome P450terp (cyp108A1) bound to alpha-terpineol | 8eul | A | CYP108A1 | 2022-10-18 | X-ray | 2.24 | cytochrome P450terp (cyp108A1) mutant F188A bound to alpha-terpineol | 8eoh | A | CYP8B1 | 2022-10-03 | X-ray | 2.65 | crystal structure of human Cytochrome P450 8B1 in complex with a C12-Pyridine Containing Steroid | 8ekt | A | CYP51AM1 | 2022-09-21 | X-ray | 2.29 | CYP51 from Acanthamoeba castellanii in complex with the tetrazole-based IND inhibitor VT-1161(VT1) | 8b2p | A | CYP153A71 | 2022-09-14 | X-ray | 1.95 | CYP153A71 from Acinetobacter dieselolei bound to octanoic acid | 8gue | A | CYP107L1 | 2022-09-11 | X-ray | 1.9 | Crystal Structure of narbomycin-bound cytochrome P450 PikC with the unnatural amino acid p-Acetyl-L-Phenylalanine incorporated at position 238 | 8gtl | A | CYP101D5 | 2022-09-08 | X-ray | 3.2 | Crystal Structure of Cytochrome P450 (CYP101D5) | 8e83 | A | CYP93C20 | 2022-08-25 | X-ray | 2.0 | Structure of 2-hydroxyisoflavanone synthase from Medicago truncatula | 8e5j | A | CYP199A4 | 2022-08-22 | X-ray | 2.3 | The crystal structure of 4-n-butylbenzoic acid bound CYP199A4 | 8dyc | A | CYP3A4 | 2022-08-04 | X-ray | 2.4 | Human CYP3A4 bound to a substrate | 8dyb | A | CYP199A4 | 2022-08-03 | X-ray | 1.88 | The crystal structure of the T252A mutant of CYP199A4 bound to 4-methylthiobenzoic acid | 8amo | A | CYP143A1 | 2022-08-03 | X-ray | 1.4 | Crystal structure of M. tuberculosis CYP143 | 8amq | A | CYP143A1 | 2022-08-03 | X-ray | 1.6 | Crystal structure of the complex CYP143-FdxE from M. tuberculosis | 8dsg | B | CYP102A1 | 2022-07-22 | X-ray | 1.87 | P411-PFA carbene transferase | 7yjh | A | CYP102A1 | 2022-07-20 | X-ray | 1.792 | Crystal structure of the P450 BM3 heme domain mutant F87V/T268I in complex with N-imidazolyl-pentanoyl-L-phenylalanine and hydroxylamine | 7yjf | A | CYP102A1 | 2022-07-20 | X-ray | 1.515 | Crystal structure of the P450 BM3 heme domain mutant F87A/T268P/V78I in complex with N-imidazolyl-pentanoyl-L-phenylalanine and hydroxylamine | 7yjg | A | CYP102A1 | 2022-07-20 | X-ray | 1.684 | Crystal structure of the P450 BM3 heme domain mutant F87A/T268V/A82C/L181M in complex with N-imidazolyl-pentanoyl-L-phenylalanine and hydroxylamine | 7yje | A | CYP102A1 | 2022-07-20 | X-ray | 1.85 | Crystal structure of the P450 BM3 heme domain mutant F87G/T268V/A184V/A328V in complex with N-imidazolyl-hexanoyl-L-phenylalanine and acetate ion | 7yjd | B | CYP102A1 | 2022-07-19 | X-ray | 1.9 | Crystal structure of the P450 BM3 heme domain mutant F87A in complex with N-imidazolyl-hexanoyl-L-phenylalanine and hydroxylamine | 8ae8 | A | CYP134C3 | 2022-07-12 | X-ray | 1.92 | Crystal structure of a staphylococcal orthologue of CYP134A1 (CYPX) in complex with a heme-coordinated fragment | 8adr | A | CYP134C3 | 2022-07-11 | X-ray | 1.92 | Crystal structure of a staphylococcal orthologue of CYP134A1 (CYPX) in complex with a fragment | 7yft | B | CYP102A1 | 2022-07-09 | X-ray | 2.0 | Crystal structure of the P450 BM3 heme domain mutant F87A/T268V/A82C/L181M in complex with N-imidazolyl-pentanoyl-L-phenylalanine, indane and hydroxylamine | 8dmg | A | CYP102A1 | 2022-07-08 | EM | 4.4 | CYP102A1 in Closed Conformation | 8dme | A | CYP102A1 | 2022-07-08 | EM | 6.5 | CYP102A1 in Open Conformation | 8dl4 | A | CYP51F1 | 2022-07-06 | X-ray | 1.91 | S. CEREVISIAE CYP51 COMPLEXED WITH Courmarin-containing INHIBITOR | 7ydb | B | CYP102A1 | 2022-07-04 | X-ray | 1.472 | Crystal structure of the P450 BM3 heme domain mutant F87V/T268I in complex with N-imidazolyl-pentanoyl-L-phenylalanine,ethylbenzene and hydroxylamine | 7ydd | A | CYP102A1 | 2022-07-04 | X-ray | 1.663 | Crystal structure of the P450 BM3 heme domain mutant F87A/T268P/V78I in complex with N-imidazolyl-pentanoyl-L-phenylalanine,propylbenzene and hydroxylamine | 7ydl | A | CYP102A1 | 2022-07-04 | X-ray | 1.58 | Crystal structure of the P450 BM3 heme domain mutant F87A/T268I/A184V/A82T in complex with N-imidazolyl-hexanoyl-L-phenylalanine | 7yde | A | CYP102A1 | 2022-07-04 | X-ray | 1.789 | Crystal structure of the P450 BM3 heme domain mutant F87T/T268V/I263V in complex with N-imidazolyl-hexanoyl-L-phenylalanine and hydroxylamine | 7ydc | A | CYP102A1 | 2022-07-04 | X-ray | 1.609 | Crystal structure of the P450 BM3 heme domain mutant F87L/T268V/V78C in complex with N-imidazolyl-pentanoyl-L-phenylalanine and hydroxylamine | 7yda | A | CYP102A1 | 2022-07-04 | X-ray | 1.557 | Crystal structure of the P450 BM3 heme domain mutant F87V/T268V/A184V in complex with N-imidazolyl-pentanoyl-L-phenylalanine and hydroxylamine | 7yd9 | A | CYP102A1 | 2022-07-04 | X-ray | 1.748 | Crystal structure of the P450 BM3 heme domain mutant F87G/T268V/A184V/A328V in complex with N-imidazolyl-hexanoyl-L-phenylalanine,methylbenzene and hydroxylamine | 8abo | A | CYP134C3 | 2022-07-04 | X-ray | 1.97 | Crystal structure of a staphylococcal orthologue of CYP134A1 (CYPX) in complex with a fragment | 8abs | A | CYP109A2 | 2022-07-04 | X-ray | 1.75 | Crystal structure of CYP109A2 from Bacillus megaterium bound with testosterone and putative ligand 4,6-dimethyloctanoic acid | 8abr | A | CYP109A2 | 2022-07-04 | X-ray | 2.1 | Crystal structure of CYP109A2 from Bacillus megaterium bound with putative ligands hexanoic acid and octanoic acid | 8aa7 | A | CYP134C3 | 2022-06-30 | X-ray | 2.05 | Crystal structure of a staphylococcal orthologue of CYP134A1 (CYPX) in complex with a heme coordinated fragment | 8a9p | A | CYP142A1 | 2022-06-29 | X-ray | 1.63 | Crystal structure of CYP142 from Mycobacterium tuberculosis in complex with a fragment | 8a91 | A | CYP134C3 | 2022-06-27 | X-ray | 1.85 | Crystal structure of a staphylococcal orthologue of CYP134A1 (CYPX) in complex with a heme-coordinated fragment | 7y9m | A | CYP102A1 | 2022-06-25 | X-ray | 2.16 | Crystal structure of P450 BM3-2F from Bacillus megaterium | 7y9l | A | CYP102A1 | 2022-06-25 | X-ray | 1.76 | Crystal structure of P450 BM3-2F from Bacillus megaterium in complex with 2-Hydroxy-5-Nitrobenzonitrile | 7y9k | B | CYP102A1 | 2022-06-25 | X-ray | 2.23 | Crystal structure of P450 BM3-TMK from Bacillus megaterium | 7y9o | A | CYP109B4 | 2022-06-25 | X-ray | 1.84 | Crystal structure of a CYP109B4 variant from Bacillus sonorensis |
|---|